Medicine

D. Hausenloy, A. Tsang, D. Yellon

2005.2.1TRENDS IN CARDIOVASCULAR MEDICINE

DOI: 10.1016/j.tcm.2005.03.001

tlooto Summary

Evidence is presented suggesting that the pharmacologic manipulation of the RISK pathway at the time of reperfusion may enable one to harness the powerful cardioprotective benefits of both ischemic preconditioning and postconditioning, and provide a novel approach toCardioprotection.

Abstract

Abstract is not available.

Citation format

HAUSENLOY, D.; TSANG, A.; YELLON, D. The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning. TRENDS IN CARDIOVASCULAR MEDICINE, 2005, 15 2: 69–75.